PfizerFounded in 1849, Pfizer is the world's largest research-based pharmaceutical company. Pfizer is taking new approaches to advancing better health as it discovers, develops, manufactures and delivers quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. Pfizer also partners with healthcare providers, governments and local communities around the world to expand access to medicines and to provide better quality health care and health system support. At Pfizer, more than 84,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide. For more information visit

Pfizer RSS Channel

Title Filter      Display #  
# Article Title
1 Pfizer announces $3 million grants program to further clinical research in advanced breast cancer
2 Pfizer acquires minority interest in AM-Pharma; secures option to acquire company
3 Pfizer and Lilly preparing to resume Phase 3 chronic pain program for Tanezumab
4 Pfizer to Acquire Hospira
5 Acquisition provides Pfizer with a preclinical CMV vaccine candidate
6 Pfizer expands rare disease research with establishment of gene therapy platform
7 Pfizer and Kyowa Hakko Kirin to collaborate on immuno-oncology combination study
8 Pfizer and Merck to collaborate on study evaluating novel anti-cancer combination regimen
9 Pfizer enters into agreement to acquire Baxter's portfolio of marketed vaccines
10 Pfizer to Acquire InnoPharma, Inc.
11 CliniWorks forms a strategic alliance with Pfizer
12 James C. Smith elected to Pfizer's Board of Directors
13 Pfizer and Cellectis enter into global strategic cancer immunotherapy collaboration
14 Pfizer opens new state-of-the-Art research and development site in Cambridge, Massachusetts
15 Pfizer and the Avon Foundation for Women announce $1 million grants program
16 Pfizer brings frequent heartburn relief OTC with new Nexium® 24HR
17 Pfizer reports first-quarter 2014 results
18 Pfizer sends letter to Rt Hon David Cameron MP regarding commitments if proposed combination with AstraZeneca is completed
19 Pfizer Confirms prior discussions with AstraZeneca
20 Eliquis® (apixaban) reduced the risk of stroke and demonstrated fewer major bleeding events versus Warfarin
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]